Respiratory Tract Diseases

At Spitalul Clinic De Boli Infectioase Si Pneumoftiziologie Victor Babes Craiova, the strongest research focus is on respiratory diseases, especially asthma, chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis. The studies are mainly designed to test new inhaled or targeted therapies, compare treatment options, and improve control of symptoms and flare-ups.

  • Asthma research covering mild, moderate, and severe forms, including eosinophilic and uncontrolled disease
  • COPD studies focused on reducing exacerbations and improving lung function
  • Idiopathic pulmonary fibrosis research aimed at slowing loss of breathing capacity

This Pneumologie department in Craiova is contributing to clinical trials that seek better long-term management and more effective respiratory care.

Immune System Diseases

The site also conducts research in immune system diseases, with a notable emphasis on asthma as an inflammatory condition. These trials are exploring whether newer therapies can better reduce airway inflammation, prevent worsening disease, and support more stable breathing over time.

  • Moderate-to-severe asthma
  • Uncontrolled moderate to severe eosinophilic asthma
  • Controlled and partly controlled asthma

Overall, the research aims to improve day-to-day disease control and lower the risk of future attacks for patients treated at this hospital.

Virus Diseases

Another important area of research is virus diseases, especially COVID-19 and hepatitis B infection. The trials are evaluating whether new antiviral or immune-based approaches can improve outcomes, reduce complications, and support better disease management.

  • COVID-19 studies focused on lowering hospitalization and death in outpatients
  • Chronic hepatitis B research examining antiviral and immune response strategies
  • Pediatric hepatitis B studies looking at treatment effectiveness and viral control

These investigations reflect the site’s role in addressing both acute and long-term infectious diseases through clinical research.